CSBR
HEALTHCAREChampions Oncology Inc
$5.98+0.01 (+0.17%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving CSBR Today?
No stock-specific AI insight has been generated for CSBR yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$5.50$9.63
$5.98
Fundamentals
Market Cap$83M
P/E Ratio—
EPS$-0.18
Dividend Yield—
Dividend / Share—
ROE-0.5%
Profit Margin-0.0%
Debt / Equity—
Trading
Volume18K
Avg Volume (10D)—
Shares Outstanding13.9M
CSBR News
20 articles- Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026Yahoo Finance·Apr 9, 2026
- Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology StrategyYahoo Finance·Mar 30, 2026
- Champions Oncology Inc (CSBR) Q3 2026 Earnings Call Highlights: Record Services Revenue and ...Yahoo Finance·Mar 19, 2026
- Champions Oncology (CSBR) Earnings TranscriptMotley Fool·Mar 13, 2026
- Champions Oncology, Inc. Q3 2026 Earnings Call SummaryMoby·Mar 13, 2026
- Champions Oncology Reports Revenue of $16.6 MillionYahoo Finance·Mar 12, 2026
- Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026Yahoo Finance·Mar 5, 2026
- Fund Discloses $25 Million Braze Stock Investment Amid 60% Share PlungeMotley Fool·Feb 20, 2026
- Battery Management Dumps $9 Million Zeta Stake as Shares Slide 38% Year Over YearMotley Fool·Feb 20, 2026
- Battery Takes $124 Million Bet on Kodiak AI. Here's What Investors Should KnowMotley Fool·Feb 20, 2026
- Is Champions Oncology, Inc.'s (NASDAQ:CSBR) Latest Stock Performance A Reflection Of Its Financial Health?Yahoo Finance·Jan 17, 2026
- Champions Oncology (CSBR) Earnings Call TranscriptMotley Fool·Jan 7, 2026
- Champions Oncology Inc (CSBR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ...Yahoo Finance·Dec 16, 2025
- Champions Oncology Reports Record Quarterly Service Revenue of $14.9 MillionYahoo Finance·Dec 15, 2025
- Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025Yahoo Finance·Dec 8, 2025
- Shareholders in Champions Oncology (NASDAQ:CSBR) are in the red if they invested five years agoYahoo Finance·Dec 7, 2025
- Champions Oncology First Quarter 2026 Earnings: US$0.032 loss per share (vs US$0.097 profit in 1Q 2025)Yahoo Finance·Sep 17, 2025
- Champions Oncology Inc (CSBR) Q1 2026 Earnings Call Highlights: Revenue Rebound and Strategic ...Yahoo Finance·Sep 16, 2025
- CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 MillionYahoo Finance·Sep 15, 2025
- Champions Oncology Reports Record Quarterly Revenue of $14.0 MillionYahoo Finance·Sep 15, 2025
All 20 articles loaded
Price Data
Open$5.82
Previous Close$5.97
Day High$5.97
Day Low$5.82
52 Week High$9.63
52 Week Low$5.50
52-Week Range
$5.50$9.63
$5.98
Fundamentals
Market Cap$83M
P/E Ratio—
EPS$-0.18
Dividend Yield—
Dividend / Share—
ROE-0.5%
Profit Margin-0.0%
Debt / Equity—
Trading
Volume18K
Avg Volume (10D)—
Shares Outstanding13.9M
About Champions Oncology Inc
Champions Oncology, Inc. develops and sells technology products and solutions to customize the development and use of cancer drugs in the United States. The company is headquartered in Hackensack, New Jersey.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—